1. With use of a positive airway pressure device without a backup rate (E0601 or E0470), the polysomnogram (PSG) shows a pattern of apneas and hypopneas that demonstrates the persistence or emergence of central apneas or central hypopneas upon exposure to CPAP (E0601) or a bilevel device without backup rate (E0470)

Respiratory Assist Device (RAD) Documentation Requirements for Continued Coverage Beyond First 3 months Patients on an E0470 or E0471 device must be reevaluated no sooner than 61 days after initiating therapy. Required Documentation • Progress of relevant symptoms

2023年11月8日 · Respiratory assist devices include devices intended to help patients in need of support for breathing, removal of carbon dioxide, and therapy to reduce disuse atrophy of abdominal wall...

2018年7月1日 · A respiratory assist device (RAD) without backup rate delivers adjustable, variable levels (within a single respiratory cycle) of positive air pressure by way of tubing and a noninvasive interface (such as a nasal or oral facial mask) to assist spontaneous respiratory efforts and supplement the volume of inspired air into the lungs.

View coverage information, documentation requirements and more for Respiratory Assist Devices.

Respiratory Assist Devices (RADs) are more complex than continuous positive airway pressure (CPAP) devices. CPAP devices deliver a single, fixed pressure to the patient during the night.

2019年1月1日 · Sleep oximetry demonstrates oxygen saturation ≤ 88% for ≥ 5 minutes of nocturnal recording time (minimum recording time of 2 hours), done while breathing the patient’s prescribed recommended FiO2. maximal inspiratory pressure is < 60 cm H2O, or forced vital capacity (FVC) is < 50% predicted.

PSG demonstrates the persistence or emergence of central apneas or central hypopneas upon exposure to CPAP or an E0470 device when titrated to the point where obstructive events have been effectively treated (AHI < 5 per hour); and.

Respiratory assist devices (RADs) are used to deliver adjustable, variable levels of positive air pressure (PAP) by way of tubing and a noninvasive interface (such as a nasal, oral or facial mask) to assist spontaneous respiratory efforts and supplement the volume of inspired air into the lungs.

Medicare provides reimbursement for bi-level positive airway pressure (PAP) devices, with and without back-up rate, for the treatment of chronic obstructive pulmonary disease (COPD) when certain specified coverage criteria are met.